We will know soon enough whether Merchant have become a substantial holder. Shares will be issued on 13 March so the substantial holder notice would come out soon after.
As for newsflow - The key is the MRD trial (Path 1). First significant results could be within about 1-2 months of dosing.
For anyone new, the point is to do chemo, then assay for complete response and determine MRD status. If there is Residual Disease then treat with Bisantrene and wait a month or two before re-assaying and then carrying out Stem Cell Transplant. The point of this is to improve probability of a successful stem cell transplant.
It is known from the historic trials that Bisantrene works as a single-agent in the fight against AML.
We should also have first results from the Israel trial by July or August ( first patient was dosed in July 2019 ).
There should be a new presentation released to coincide with the Perth presentation on Thursday.
Ann: Race Secures A$1.8m strategic placement, page-55
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.010(0.56%) |
Mkt cap ! $304.2M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.80 | $1.78 | $106.4K | 59.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 600 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.83 | 10000 | 2 |
View Market Depth
| Last trade - 15.57pm 30/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |